Intramural Hematoma

How to Cite This Chapter: Szalay D, Frołow M, Leśniak W. Intramural Hematoma. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. https://empendium.com/mcmtextbook/chapter/B31.II.2.131.1. Accessed December 05, 2025.
Last Reviewed: February 20, 2025
Last Updated: February 20, 2025
Chapter Information

Definition, Etiology, PathogenesisTop

Aortic intramural hematoma (IMH) is a type of acute aortic syndrome in which blood accumulates in the media of the aortic wall but no false lumen/blood flow has developed. An intimal tear may or may not be present. Just like acute aortic dissection, IMH may be divided into type A or type B and generally presents as chest or back pain without evidence of rupture or malperfusion.

The greatest concern with intramural hematomas is the risk of progression to aortic enlargement, dissection, or rupture.

Natural HistoryTop

In 30% to 40% of patients with IMH type A, aortic dissection occurs (the risk is highest within 8 days of symptom onset).

DiagnosisTop

Computed tomography (CT) and magnetic resonance imaging (MRI) are the key diagnostic studies used to diagnose and classify IMH.

TreatmentTop

1. Medical treatment: Control of pain and blood pressure. Repeat imaging studies.

2. Invasive treatment:

1) In IMH type A coexisting with a pericardial effusion, periaortic hematoma, or large aneurysm, start emergency surgical treatment.

2) In other cases of IMH type A, urgent surgical treatment is necessary (within <24 hours of diagnosis), although in many elderly patients and those with significant comorbidities initial medical treatment may be justified (provided the aortic diameter is ≤50 mm and thickness of the intramural hematoma is <11 mm).

3) In IMH type B, medical management is the primary treatment but invasive treatment (usually endovascular stenting) is indicated in case of complications such as rupture; persisting, refractory, or recurrent pain; hematoma expansion; periaortic hematoma; or disruption of the intima. Just as for type B dissections, there is a group of patients with IMH with high-risk features, which include a large maximum aortic diameter (>47-50 mm), increased IMH thickness (>13 mm), development of focal intimal disruption with ulcer-like projection into the media, progression to dissection, organ ischemia (brain, myocardium, bowels, kidneys), difficult to control blood pressure, ascending aortic involvement, or increasing or recurrent pleural effusion. Decisions about stenting in patients with type B IMH and high-risk features are made on an individualized basis.

We would love to hear from you

Comments, mistakes, suggestions?